Logo

Alkem Laboratories Share Price

NSE: ALKEM
|
Pharmaceuticals
₹ 5,577.00
+₹76.50 (1.39%)
1D
Last updated 03 Jul, 2026, 15:29 IST

Alkem Laboratories Share Price Today

As of 3 Jul 2026, Alkem Laboratories share price is ₹5,577.00. The stock opened at ₹5,510.50, compared to its previous close of ₹5,500.50. During today's trading session, Alkem Laboratories share price moved in the range of ₹5,494.00 to ₹5,631.00, with an average price of ₹5,562.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,716.20 and a high of ₹5,933.50. On the performance front, Alkem Laboratories share price has declined by 0.54% over the last six months and is up 15.36% on a year-on-year basis.

₹5,494.00
1.39% up today
₹5,631.00
1D LOW
1D HIGH

Alkem Laboratories Returns Calculator

Open
₹5,510.50
High
₹5,631.00
Low
₹5,494.00
Prev. close
₹5,500.50
Circuit
L
H
₹4,950.50
₹6,050.50
52-week
L
H
₹4,716.20
₹5,933.50

Alkem Laboratories Shareholder Returns

Alkem Laboratories Share Price History

Mkt Cap Cr
65,712.30
P/E
27.95
P/B
4.75
ROE
16.66%
D/E
0.04
ROCE
18.61%
Div. Yield
0.96%
EPS(TTM)
182.76
Turnover
0.67
EV/EBITDA
19.59
Net Margin
0.00%
Op. Margin
0.00%
ROA
11.27%
Quick Ratio
0.00
Curr. Ratio
3.57
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Alkem Lab outperforming all market indices
Step 2 of 5
Valuation
Expensive
Alkem Lab PE is significantly higher than its peers
Step 3 of 5
Earnings
Neutral
Alkem Lab earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Alkem Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹12,964.52₹12,667.58₹11,599.26₹10,634.19
Other Income₹493.74₹310.84₹216.08₹162.65
Total Revenue₹13,458.26₹12,978.42₹11,815.34₹10,796.84
Total Expenses₹10,931.23₹10,833.80₹10,407.59₹8,937.60
Profit Before Tax₹2,527.03₹2,023.13₹1,304.77₹1,844.28
Tax₹311.03₹211.67₹297.96₹163.96
Profit After Tax₹2,216.00₹1,811.46₹1,006.81₹1,680.32
EPS - Basic₹181.11₹150.19₹82.31₹137.63
EPS - Diluted₹181.11₹150.19₹82.31₹137.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹2,527.03₹2,023.13₹1,304.77₹1,844.28
Income before WC changes₹2,630.83₹2,406.70₹1,629.12₹2,052.88
Change in Assets-₹454.79-₹430.50₹261.69-₹938.47
Change in Liabilities₹240.82₹378.81₹65.08₹393.51
Change in WC-₹213.97-₹51.69₹326.77-₹544.96
Cash flow from Operations₹1,912.84₹1,948.07₹1,682.50₹1,111.02
Cash flow from Investing-₹1,298.76-₹1,008.50₹112.84-₹1,435.13
Cash flow from Financing-₹810.99-₹1,145.01-₹1,760.82₹379.57
Total Cash Flow-₹196.91-₹205.44₹34.52₹55.46
Cash (Start of the year)₹66.31₹273.80₹232.18₹174.22
Cash (End of the year)-₹120.09₹66.31₹273.80₹232.18

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹6,879.91₹5,163.32₹5,026.95₹5,635.49
Current Assets₹10,811.19₹10,411.58₹8,729.70₹8,433.70
Total Assets₹17,691.10₹15,574.90₹13,756.65₹14,069.19
Current Liabilities₹3,958.69₹3,994.55₹3,707.15₹4,805.34
Net Current Asset₹6,852.50₹6,417.03₹5,022.55₹3,628.36
Non-Current Liabilities₹1,298.78₹865.95₹614.50₹416.52
Equity Capital₹12,433.63₹10,714.40₹9,435.00₹8,847.33
Total Equity & Liabilities₹17,691.10₹15,574.90₹13,756.65₹14,069.19

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹8,813.44₹7,963.85₹9,054.55₹8,829.81
Other Income₹507.06₹305.99₹266.29₹199.89
Total Revenue₹9,320.50₹8,269.84₹9,320.84₹9,029.70
Total Expenses₹7,016.96₹6,611.88₹7,993.85₹7,276.33
Profit Before Tax₹2,303.54₹1,594.13₹1,326.99₹1,753.37
Tax₹213.82₹33.62₹192.52₹212.12
Profit After Tax₹2,089.72₹1,560.51₹1,134.47₹1,541.25
EPS - Basic₹190.77₹146.13₹94.88₹128.90
EPS - Diluted₹190.77₹146.13₹94.88₹128.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹2,597.39₹1,881.03₹1,326.99₹1,753.37
Income before WC changes₹2,546.05₹2,092.77₹1,455.88₹1,861.36
Change in Assets-₹179.20-₹238.27₹169.14-₹594.55
Change in Liabilities₹219.19₹184.89₹36.56₹367.38
Change in WC₹39.99-₹53.38₹205.70-₹227.17
Cash flow from Operations₹2,189.41₹1,686.56₹1,437.42₹1,299.34
Cash flow from Investing-₹1,007.41-₹865.60₹197.04-₹1,669.33
Cash flow from Financing-₹1,036.89-₹959.04-₹1,711.27₹436.59
Total Cash Flow₹145.11-₹138.08-₹76.81₹66.60
Cash (Start of the year)-₹133.07₹5.01₹81.82₹15.22
Cash (End of the year)₹12.04-₹133.07₹5.01₹81.82

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹8,241.60₹5,997.72₹5,959.01₹6,308.56
Current Assets₹7,354.00₹8,040.08₹6,772.21₹6,860.61
Total Assets₹15,595.60₹14,037.80₹12,731.22₹13,169.17
Current Liabilities₹2,543.44₹3,106.40₹3,044.83₹4,123.76
Net Current Asset₹4,810.56₹4,933.68₹3,727.38₹2,736.85
Non-Current Liabilities₹730.33₹376.79₹336.54₹301.75
Equity Capital₹12,321.83₹10,554.61₹9,349.85₹8,743.66
Total Equity & Liabilities₹15,595.60₹14,037.80₹12,731.22₹13,169.17
* All values are in INR Crore
Qty
Bid
43
5562.5
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 43
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.25
Neutral
ATR (14)
91.18
Neutral
STOCH(9,6)
54.74
Neutral
STOCH RSI (14)
63.26
Neutral
ADX(9)
43.75
Bearish
UO(9)
39.28
Neutral
ROC(12)
3.12
Bullish
WillR(14)
-38.9
Neutral
Period
Simple value
Exponential vaue
5D
5495.9
5498.51
10D
5443.6
5457.98
20D
5380.23
5422.22
50D
5422.91
5418.82
100D
5450.06
5453.58

About Alkem Laboratories

Alkem Laboratories logo
ISIN
INE540L01014
Sector Market Cap
₹ 65,712.3 Cr

Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.

Alkem Laboratories Financial Highlights

  • Revenue: Alkem Laboratories reported revenue of ₹15,295.62 crore in FY26 vs ₹13,458.26 crore in FY25. It showed an increase of 13.65% on a yearly basis.
  • Operating Profit: Alkem Laboratories reported an operating profit of ₹2,870.89 crore in FY26 vs ₹2,527.03 crore in FY25. It showed an increase of 13.61% on a year-on-year basis.
  • Net Profit: Alkem Laboratories reported a net profit of ₹2,353.13 crore in FY26 vs ₹2,216.00 crore in FY25. It showed an increase of 6.19% on a yearly basis.

Alkem Laboratories Quarterly Result Highlights

  • Alkem Laboratories reported revenue of ₹3,803.39 crore in Mar 2026, compared with ₹3,879.92 crore in Dec 2025, representing a decrease of 1.97% on a quarter-on-quarter (QoQ) basis.
  • Alkem Laboratories reported an operating profit of ₹422.85 crore in Mar 2026, compared with ₹781.20 crore in Dec 2025, representing a decrease of 45.87% on a quarter-on-quarter (QoQ) basis.
  • Alkem Laboratories reported a profit of ₹251.68 crore in Mar 2026, compared with ₹653.53 crore in Dec 2025, reflecting a decrease of 61.49% on a QoQ basis.
  • The earnings per share (EPS) of Alkem Laboratories stood at ₹181.11 during Mar 2026.
Know more
Promoters
51.20%
FII
10.16%
Other DII
5.83%
Retail and other
17.25%
Mutual funds
15.57%
Foreign institutions - FII
Compare against other stocks
Alkem Laboratories logo
Alkem Laboratories
Pharmaceuticals
Add Stock
Add Another

FAQs on Alkem Laboratories Share Price